We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Sprayable Powder-Type Hemostatic Agent Stops Bleeding in One Second

By HospiMedica International staff writers
Posted on 12 Jan 2026

Uncontrolled bleeding remains the leading cause of preventable death from injuries. More...

Rapid blood loss can be fatal within minutes, especially when wounds are deep, irregular, or difficult to compress. Existing hemostatic patches are often ineffective in such scenarios and can be impractical in harsh environments. New research now presents a spray-on powder that can stop bleeding within one second, offering a potential breakthrough for emergency care, especially in medically underserved areas.

An interdisciplinary team of researchers at the Korea Advanced Institute of Science and Technology (Daejeon, South Korea) has designed a powder-type hemostatic agent optimized for emergency medicine. The agent rapidly transforms into a strong hydrogel barrier upon contact with blood, enabling immediate wound sealing without complex preparation.

The researchers focused on overcoming the limitations of flat, patch-based hemostatic products by creating a free-flowing powder suitable for deep and irregular wounds. The formulation, known as AGCL powder, combines naturally derived materials including alginate and gellan gum, which undergo ultra-fast gelation in the presence of calcium ions, and chitosan, which enhances biological clotting through interaction with blood components. The powder’s internal three-dimensional structure was engineered to maximize blood absorption and adhesion.

The AGCL powder gelled within approximately one second after application and absorbed more than seven times its own weight in blood. It demonstrated strong sealing performance under high-pressure bleeding, with adhesive strength exceeding 40 kPa, outperforming commercial hemostatic agents. Safety testing showed low hemolysis, high cell viability, and strong antibacterial activity. In animal models, the powder reduced bleeding time, promoted tissue regeneration, and supported normal organ recovery without systemic toxicity.

The hemostatic agent maintained performance for up to two years under room temperature and high-humidity conditions, making it suitable for storage and rapid deployment in resource-limited settings. The technology could be used widely in emergency medicine, trauma care, and humanitarian response, where rapid bleeding control is critical.

Related Links:
KAIST


Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hypodermic Syringe
SurTract™ Safety Syringe
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.